Skip to main content
. 2011 Oct 27;26(11):1439–1445. doi: 10.3346/jkms.2011.26.11.1439

Table 2.

Biometric analysis of control and KITENIN shRNA-treated tumors in the primary therapy model

graphic file with name jkms-26-1439-i002.jpg

*P < 0.05, compared with control tumors according to χ2 test (for incidence) and Student's two-tailed t test.